Stay updated with breaking news from Advanced Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "US Hypersonics Market 2021: State of the Industry" report has been added to ResearchAndMarkets.com's offering. This analysis provides the...
J&J vaccine production could restart in U.S. 'within days,' Emergent executive testifies POLITICO 5 hrs ago By Sarah Owermohle © Stefani Reynolds/The New York Times via AP, Pool Robert Kramer, president and CEO of Emergent BioSolutions, speaks via videoconference during a hearing on Capitol Hill. Emergent BioSolutions could resume manufacturing Johnson & Johnson's Covid-19 vaccine within days, CEO Robert Kramer told a House panel Wednesday. The Food and Drug Administration ordered Emergent to pause production last month after a series of manufacturing problems at its Balt...
Fewer than 24 hours to save $100 to attend TC Sessions: Mobility 2021 Calling all frazzled procrastinators, feet-draggers, lollygaggers and last-minute decision makers. The best price on passes to TC Sessions: Mobility 2021, which takes place on June 9, disappears in mere hours. It’s now o’clock, baby. Shift your EV into gear, hail a robotaxi or tell Mr. Scott to beam you up — whatever it takes to buy your pass before the early-bird deadline expires tonight, May 6, at 11:59 pm (PT). TC Sessions: Mobility 2021 gathers the very best people in the mobility startup ecosystem to discuss the...
Lyft sells self-driving unit to Toyota’s Woven Planet for $550M Ride-hailing company Lyft has sold off its autonomous vehicle unit to Toyota’s Woven Planet Holdings subsidiary for $550 million, the latest in a string of acquisitions spurred by the cost and lengthy timelines to commercialize autonomous vehicle technology. Under the acquisition agreement announced Tuesday, Lyft’s so-called Level 5 division will be folded into Woven Planet Holdings. Lyft will receive $550 million in cash, with $200 million paid upfront. The remaining $350 million will be made in payments over five years. A...
European regulators decline to restrict use of Johnson & Johnson vaccine, call blood clots very rare Updated April 20, 2021, 1 hour ago Email to a Friend Mexican President Andres Manuel Lopez Obrador was inoculated with the first dose of the Astra Zeneca vaccine Tuesday.PEDRO PARDO/AFP via Getty Images WASHINGTON â European regulators said Tuesday that Johnson & Johnsonâs coronavirus vaccine may be tied to very rare blood clots, but they placed no restrictions on its use in the European Union. The decision, by the European Medicines Agency, was based on the same US data that led Ame...